Assisting AI medical devices in conducting clinical trials to obtain health impact and medical economic assessments
The AI Impact Research Center of Taipei Veterans General Hospital assists AI medical devices (AI-SaMD) that have obtained Taiwan FDA approval in conducting clinical trials, aiming to obtain comprehensive health impact and medical economic assessments, with the ultimate goal of helping products apply for national health insurance coverage. The following details the trial process, standards, and market strategies.
The market strategy services provided by the center are as follows: